Results 191 to 200 of about 76,033 (333)

C‐Reactive Protein Serum Values in Idiopathic and Autoimmune Subglottic Stenosis

The Laryngoscope, EarlyView.
This study characterized C‐reactive protein (CRP) levels in idiopathic and granulomatosis with polyangiitis‐related (GPA) subglottic stenosis (SGS) to assess CRP ability to distinguish SGS subtypes and predict recurrence. High CRP levels are more frequent in GPA‐SGS, potentially aiding clinical differentiation of etiologies.
Andrew J. Neevel, Fatemeh Ramazani, Julia Ford, Ora Gewurz‐Singer, Norman D. Hogikyan, Robert J. Morrison, Robbi A. Kupfer   +6 more
wiley   +1 more source

The Impact of Estrogen on Stromal Elements in the Proximal Airway in Idiopathic Subglottic Stenosis

The Laryngoscope, EarlyView.
ABSTRACT Objectives Idiopathic subglottic stenosis (iSGS) is an unexplained fibrosis of the proximal airway that predominantly impacts Caucasian women. Clinically, premenopausal patients suffer from higher recurrence rates, potentially implicating ovarian hormone 17B‐estradiol (E2) in disease pathogenesis.
Emily L. Mace, Evan Clark, Edward Talatala, Maxim Litvak, Matthew A. Buendia, Yash A. Choksi, Hongmei Wu, Yueli Zhang, Alexander Hillel, Sam Collins, Quanhu Sheng, Jing Yang, Jason Park, Alexander Gelbard   +13 more
wiley   +1 more source

Prevalence of White Coat Hypertension in Patients with Chronic Kidney Disease

, 2018
Rozita Mohd, Noor Hidayah Yahya, Rizna Abdul Cader, Abdul Halim Abdul Gafor, Yazmin Yaacob, Rozita Hod   +5 more
openalex   +2 more sources

Prevalence of White Coat Hypertension in Underweight and Overweight Subjects

, 2007
Mehmet Rami Helvacı, Hasan Kaya, Atilla Yalçın, Güven Kuvandık   +3 more
openalex   +2 more sources

White Coat Hypertension in Children and Adolescents.

HYPERTENSION, 2019
C. Hanevold
semanticscholar   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source

Complications of White-coat Hypertension Compared to a Normotensive and Hypertensive Population.

Heart Views, 2021
Taher ZA, Khayyat WW, Balubaid MM, Tashkandi MY, Alamoudi SM, Kinsara AJ.   +5 more
europepmc   +1 more source

Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial

Movement Disorders, EarlyView.
Abstract Background Neuroinflammation contributes to Parkinson's disease (PD) progression and motor dysfunction. Allogeneic human mesenchymal stem cells (allo‐hMSCs) may reduce neuroinflammation and improve motor symptoms. Objectives To evaluate the efficacy of repeated intravenous doses of 10 × 106/kg allo‐hMSCs in improving motor symptoms in patients
Mya C. Schiess, Jessika Suescun, Juan D. Martinez‐Lemus, Charles Green, Tia S. Thomas, Mohammad Shahnawaz, Emily Tharp, Nikunj B. Satani, Jerome G. Saltarrelli, Christopher Adams, Marie‐Francoise Doursout, Vanessa Thyne, Rula Abuamouneh, Elsa M. Rodarte, Sean I. Savitz, Timothy M. Ellmore   +15 more
wiley   +1 more source

Prognostic Impact of Different Definitions of White-Coat Hypertension. [PDF]

Am J Hypertens
Verdecchia P, Coiro S, Bartolini C, Aita A, Borgioni C, Repaci S, Dembech C, Guerrieri M, Sacchi N, Bistoni S, Trottini M, Angeli F.   +11 more
europepmc   +1 more source

Cardiovascular Alterations and Management of Patients With White Coat Hypertension: A Meta-Analysis. [PDF]

Front Pharmacol, 2020
Xiang H, Xue Y, Wang J, Weng Y, Rong F, Peng Y, Ji K.   +6 more
europepmc   +1 more source